Airsculpt Technologies, Inc. AIRS

Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgery.

AirSculpt Technologies (AIRS) is back in focus after reporting Q2 2026 results that showed slightly lower sales and a wider net loss, while management reaffirmed full year revenue guidance at the lower end of its range. See our latest analysis for AirSculpt Technologies. The Q2 2026 earnings release and reaffirmed revenue outlook have landed after a period of sharp share price swings for AirSculpt Technologies, with the stock up strongly year to date but total shareholder return over the past...

Despite a 2.5% revenue dip, the company posts its second consecutive quarter of case growth and expands its procedure portfolio to capture the GLP-1 market.

AirSculpt Technologies reported past second-quarter 2026 results showing sales of US$42.9 million versus US$44.01 million a year earlier and a wider net loss of US$1.11 million, while six-month sales slipped to US$82.29 million with a modestly higher cumulative net loss of US$3.51 million. Despite the softer top line and continued losses, the company reaffirmed its full-year 2026 revenue outlook at the lower end of its US$151 million to US$157 million guidance range, signaling management’s...

AirSculpt Technologies, Inc. (NASDAQ:AIRS) shares tumbled 13.

Same Center Cases Up 1% for the Second Consecutive QuarterMIAMI BEACH, Fla., Aug. 10, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the second quarter ended June 30, 2026. Yogi Jashnani, Chief Executive Officer, stated: “In the second quarter, we advanced our key priorities — delivering our second quarter of stability. During the quarter, we stepped up our i

Company to Participate in Canaccord Genuity's 46th Annual Growth ConferenceMIAMI BEACH, Fla., Aug. 03, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report second quarter 2026 financial results before market open on Monday, August 10, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time. The earnings conference call ca

MIAMI BEACH, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt” or the “Company”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced that the Company will participate in upcoming investor conferences. On June 3, 2026, the Company will participate in the TD Cowen 10th Annual Future of the Consumer Conference being held at the Lotte New York Palace in New York City. Management will host a fireside chat presentation a

Same Center Sales Increase 1% and Reaffirms Fiscal Year 2026 OutlookMIAMI BEACH, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the first quarter ended March 31, 2026. Yogi Jashnani, Chief Executive Officer, stated: “We had a solid start to the year delivering stabilization in revenue, positive same center sales, and a strengthened balance sheet